In class transition from bortezomib-based therapy to IRd is an effective approach in newly diagnosed multiple myeloma - Supplementary Material
收藏DataCite Commons2024-05-15 更新2025-04-15 收录
下载链接：
https://tandf.figshare.com/articles/dataset/In_class_transition_from_bortezomib-based_therapy_to_IRd_is_an_effective_approach_in_newly_diagnosed_multiple_myeloma_-_Supplementary_Material/24270778
下载链接
链接失效反馈官方服务：
资源简介：
Supplementary Figure S1. Study design and timelinesSupplementary Figure S2. Populations for the IRd and V-based cohorts Selected from US MM-6 and INSIGHT MM.Supplementary Table S1. Patient baseline and disease characteristics before IPTW.Supplementary Table S2. Duration of treatment with individual agents in the IRd and V-based IPTW-weighted cohorts.Supplementary Table S3. Stem cell transplant and subsequent PI therapy in the V-based IPTW-weighted cohort.<br>
提供机构：
Taylor & Francis
创建时间：
2023-10-09
